Andreas Pahl
Chief Executive Officer bei HEIDELBERG PHARMA AG
Profil
Dr. Andreas Pahl is a Managing Director at Heidelberg Pharma Research GmbH and a Chief Executive Officer at Heidelberg Pharma AG.
Dr. Pahl was previously employed as a Chief Scientific Officer by Heidelberg Pharma AG /Old/, a Member-Supervisory Board by Emergence Therapeutics AG, a Professor-Pharmacology & Toxicology by Friedrich-Alexander University of Erlangen-Nuremberg, a Head-Late Pharmacology by Nycomed GmbH, a Head-Late Pharmacology by Takeda Pharmaceutical Co., Ltd., and a Professor by Technical University of Berlin.
He received his undergraduate degree from Humboldt-Universität zu Berlin.
Aktive Positionen von Andreas Pahl
| Unternehmen | Position | Beginn |
|---|---|---|
| HEIDELBERG PHARMA AG | Chief Executive Officer | 01.02.2024 |
Heidelberg Pharma Research GmbH
 Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Heidelberg Pharma AG, Heidelberg Pharma Research GmbH is a German company that engages in researching biotechnology. The company is based in Ladenburg, Germany. The private company was founded in 2011. Andreas Pahl has been the CEO of the company since 2012. | Chief Executive Officer | 01.02.2024 |
Ehemalige bekannte Positionen von Andreas Pahl
| Unternehmen | Position | Ende |
|---|---|---|
| Nycomed GmbH | Corporate Officer/Principal | - |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - |
Emergence Therapeutics AG
 Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Director/Board Member | - |
| Friedrich-Alexander University of Erlangen-Nuremberg | Corporate Officer/Principal | - |
| Technical University of Berlin | Corporate Officer/Principal | - |
Ausbildung von Andreas Pahl
| Humboldt-Universität zu Berlin | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| HEIDELBERG PHARMA AG | Health Technology |
| Private Unternehmen | 4 |
|---|---|
| Nycomed GmbH | |
Heidelberg Pharma Research GmbH
Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Heidelberg Pharma AG, Heidelberg Pharma Research GmbH is a German company that engages in researching biotechnology. The company is based in Ladenburg, Germany. The private company was founded in 2011. Andreas Pahl has been the CEO of the company since 2012. | Commercial Services |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Health Technology |
Heidelberg Pharma AG /Old/
 Heidelberg Pharma AG /Old/ Miscellaneous Commercial ServicesCommercial Services Heidelberg Pharma AG provides drug development services. The firm also provides services for the pre-clinical development of new chemical or biological entities, which includes drug metabolism- and pharmacokinetic (DMPK) studies and pharmacology services in the field of cancer, inflammatory and autoimmune diseases. The company was founded in 1999 and is headquartered in Ladenburg, Germany. | Commercial Services |
